foxo4-dri human trial peptide senolytic Development of a novel senolytic by precise disruption of FOXO4 FOXO4-DRI: The Senolytic Peptide That

Tao et al., 2016)

D., Goldstein, J

When you receive BPC-157 at our regenerative medicine clinic in Tampa, you know exactly what you are getting, how much you are getting, and that it has been prepared safely for human use

It was first isolated and characterised by Professor Predrag Sikiric and his research group at the University of Zagreb in the early 1990s, with the foundational paper published in the Journal of Physiology (Paris) in 1993

Lyophilized peptides typically last one to two years refrigerated, while reconstituted peptides in the fridge remain stable for two to four weeks under optimal conditions

BPC-157 has become increasingly popular for a variety of health issues